Imerys Sa Ord

And thank you for standing by. Welcome to the IMRS 2025 First Nine Months and Third Quarter Results Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1, 1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 1, 1 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speakers today, Alessandro Dazza, Chief Executive Officer, and Sebastian Rouge, Chief Financial Officer. Please go ahead.

Thank you. Good afternoon or good evening to all of you, and thank you for joining us today to review Imerys' first nine months and Q3 2025 results. Next to me this evening, as usual, Sébastien Rouge, our CFO. And as usual, please let me start by giving you some highlights for the nine months we just closed. Imerys' performance for the nine months is the result of a positive start to the year and a softer second part. Q3 reflected an honestly unexpected slowdown in the U.S. economy as a result of uncertainty caused by the U.S. terrorist policy. Europe, even if overall activity remains low, seems to be turning the corner positively. Revenue for the first nine months were $2,583,000,000, slightly down 0.7%, like for like versus last year. Even in this context, which remains challenging, Emeris posted an EBITDA of 421 million in line with last year, like for like, and excluding the contribution of joint ventures. This demonstrates the resilience of our company, also in difficult times. The adjusted EBITDA for the third quarter, 25, was 140 million, representing a 17% margin. And again, reflecting disciplined pricing policy, ongoing continuous cost management, and positive business dynamic in the polymer and additive businesses. For the full year 2025, the group confirms its adjusted EBITDA target in the range of 540 to 580 million euro. Last importance, as we do not see a significant market recovery, or at least is being delayed, on top of the ongoing actions on costs, and I will come back to this, the group is launching a comprehensive cost reduction and performance improvement program aimed at simplifying its organization and adjusting its industrial footprint to restore profitability. Finally, some key updates of the quarter. First on Emily. Imerys has received an indication of interest from a potential investor to acquire a minority stake in the Emily Lithium project. Classic subject to customary due diligence and approvals, this investment will be formalized by the end of January 26 and would allow the completion of the definitive feasibility study of the commercial plans, sometimes around the end of next year. Consequently, any decision concerning future phases, such as the construction of the industrial pilot plant, are on hold and will be made in due course based on market conditions and capital allocation considerations. Second, important good news, Imerys signed today an agreement to purchase SB MineralSao in Brazil. SB Mineração is a Brazilian company specialized in the production of ground calcium carbonate, or GCC, based in Cachoeiro in the state of Espírito Santo. The company is a leading producer of GCC for various applications, in particular polymers, thermosets, paints, and coatings. In 24, the business generated approximately $30 million in revenue with a solid profitability. With this acquisition, Imerys would strengthen It's footprint in Brazil, where it is already one of the main producers of carbonates. The completion of the transaction is subject to customary closing conditions, including regulatory approvals. A word on our decarbonization roadmap. We signed an important partnership in October with ENGIE to supply green energy to approximately 25% of our European operations. via a 10-year corporate purchase agreement for the annual generation of 200 gigawatt hour of renewable electricity in Spain. This agreement will enable the reduction of 70,000 tons of CO2 equivalent per year, or 14% of our scope 2 emissions, so a significant step. Our Imerys graphite and carbon business signed two strategic partnerships aiming at enlarging its innovative product portfolio for batteries. One is with C-Nano, the global leader in carbon nanotubes. The second one with Shanghai Shanshan, which is the global leader in synthetic graphite for lithium ion batteries. I will not enter the details, and more details are available on our website on the two specific projects. What is important, both partnerships directly address Europe's crucial need for a regional, resilient, and competitive battery supply chain based on state-of-the-art technologies. If we move on now to the next slide, you see Emery sales performance by geography for the first nine months, which is a good picture of the a bit contrasted economic activity by area. Europe, you know, represented about 50% of our sales, or slightly less, enjoyed finally a light recovery in Q3, thanks to improving construction and industrial activity. And you see this if you compare to what we published in July last year. with the Q2 results. Nevertheless, on a full-year basis, year-to-date, business is still lagging behind last year, and we know due to soft activity in industrial sector and a poor construction market until recently. North America, the big surprise of the quarter, really subduing Q3, confirming a trend that we have seen at the end of Q2, mostly affected by tariffs. a weak industrial or weak, sorry, residential markets, and a bad quarter infiltration, partly, frankly, relating to our own production issues, relating to CAPEX and some industrial topics. For the nine months, sales are basically flat compared to last year or in line with previous year. We should not forget the significant impact of the devaluation of the U.S. dollar, negatively impacting sale at the level of 4% compared to last year, so becoming significant. In Asia, sales are growing nicely, not only in India, but also in China, which remains quite dynamic, especially around new technologies, electric vehicles, and strong exports in general. Very strong first half, a bit weaker Q3, but I remain confident it will be a good year in South America. The next slide, as usual, a deep dive on what really shows the robustness of Emery's business model. On the left side, you can see the evolution of our adjusted EBITDA year on year. We do have a significant impact of perimeter, as we saw before, coming from the divestiture of the assets serving the pay the paper market, last year in July. End of joint ventures, as we have been discussing since the beginning of this year. FX playing a role, as I mentioned before, but fundamentally the core of Imerys activity remains solid and adjusted EBITDA was resilient, almost flat compared to last year. On the right side, the balance price costs, which highlights the good, continuous work done on cost reductions, first of all, but also on eMERI's agility to react to market changes in terms of pricing when needed. We know this balance remains a key factor for future success. Let's now look at our main underlying markets and their trends. And I'll be quick, as we have partly already addressed the main trajectories and trends by geography. So overall, I would say what we saw in Q2 was confirmed in Q3, with overall markets below expectation, especially construction and automotive, while growth in electric vehicles continues strongly. And while tariffs have a limited direct impact on Imerys, the uncertainty created by these tariffs is impacting more in general business activity and unfortunately specifically some of our customers. To rapidly conclude on this side, construction finally and potentially restarting in Europe remains below expectation in the U.S. Consumer goods, resilient, certainly in the U.S., maybe slowing a bit in America for the reasons we have mentioned. Automotive, continued low production levels in Europe and in North America. China, good, benefited from strong exports, but also these internal stimulus packages or policies launched by the government, and of course, very strong EV growth in the area. General industrial activity, soft in Q2 in Western economies, strong or solid in China. So far for market trends. Sébastien, I hand over to you for more details on our accounts.

Thank you, Alessandro. Good evening, everyone. Let me recap some of the key aspects of our financial performance, and we'll start with revenue. report sales at 2.6 billion for the first nine months of 2025. It represents 0.7% decrease at constant exchange rate and perimeter as compared to last year, with volumes slightly down and prices holding well. You keep in mind the large perimeter effect, 126 million, mainly due to the disposal of the assets serving paper in July 24. We have now an FX impact of minus 47 million, coming from a drop mostly of the USD versus Euro from Q2 onwards. You can see in the chart Imerys' performance for the third quarter alone, quite similar trend for sales volume and prices, and also an high FX impact. Perimeter effect is now positive thanks to the good performance of Chem Viron, the business acquired at the end of last year. If we look now into more details at our three business segments, Beginning with performance minerals, the business generated 1,547,000,000 since the beginning of 25, representing 60% of Imerys Group. Overall, the business shows slightly negative organic growth as compared to last year due to a weak Q3 notably in America. Revenue in Q3 for Americas was down 5.7% at constant scope and exchange rate, reaching 199 million euros. Sales were impacted by a weak residential market in the U.S., suffering from high interest rates, unsold housing inventory, and also a soft filtration market. The prices held well. Revenue in Q3 for EMEA and APAC decreased by 3% at like-for-like in the third quarter of 2025 as compared to last year. Weak volumes, minus 4.1%, were driven by low demand across main markets, where our sales to paints and automotive polymer slightly improved. I already mentioned the good performance of ChemViron's diatomite and perlite businesses, integrated since January 25. Here as well, price grew in line with H1. Now looking at our solutions for refractory, abrasives, and construction business. We note a relative improvement of the business in Q3. posting organic growth in the quarter after a difficult H1. Business revenue reached $278 million in Q3, an increase of 1.9% as compared to last year at constant scope and exchange rate. The recovery is primarily driven by stronger refractory activity, benefiting from positive momentum in the US and China, and some volume gains in Europe. In contrast, the construction business experienced a more mixed performance, impacted by soft-end markets. In this business, prices as well held well. Now, let's complete this segment review with the solutions for energy transition. Q3 revenues for graphite and carbon amounted to 59 million, a 3.6% increase compared to last year at constant scope and exchange rate. Sales growth is still driven by robust end markets, primarily electric vehicles. The business also benefited from successful new product launches, in particular in polymer applications. A small note on the quartz corporation, our high purity quartz JV, 50% owned by Emeris and not consolidated, as you remember. The activity is showing some signs of normalization. However, this has yet to be confirmed as the solar value chain remains affected by persistent high inventories and the lack of significant reduction in production capacity. Now, let's look at the group profitability. For the first nine months, adjusted EBITDA reached 421 million. It decreased by 21% as compared to last year, reflecting the impact of lower contribution of JVs, perimeter impact, and an unfavorable exchange rate effect of minus 11 million. and adjusted EBDA margin of 16.3% at the end of Q3-25. This was supported by improved performance in graphite and carbon, resilient activity in performance mineral, and a continuous cost management approach. Adjusted EBDA Q3-25 decreased by 6%, impacted by volume decrease and a 10 million FX impact. which were partly offset by a positive price-cost balance in this quarter again. Ongoing cost-saving initiatives allowed the group to keep fixed cost and overhead slightly lower than last year in absolute value, fully offsetting inflation. If we look now at the other elements of our income statement for the first nine months of this year, Driven by the decrease of EBITDA in absolute value, current operating income reached $216 million. With slightly higher interest expenses and lower income tax, current and empty income from continuing operation ended up at $126 million at the end of September. You remember that last year, the group booked 326 million in non-cash expenses, mostly originating from the translation reserves associated with the assets serving the paper market that we divested in July 24. This year, in the first nine months of 25, other operating expenses were limited to 16 million. Year-to-date net profit is therefore positive, reaching $110 million at the end of September. I now hand over back to Alessandro for the outlook.

Thank you, Sébastien. So, let me conclude with some good news. First, we remain confident of achieving our guidance, which is not a given under current market circumstances. Second, I'd like to inform you that the date has been set by the relevant court to resume the confirmation hearing on our Chapter 11 case in the U.S. This is now planned to start on February 2nd next year. Yes, we all wish it could be earlier, but this was the first available date provided by the court. What is important is having a date for this crucial hearing is a very important step towards the end of this process. Third, as you have seen at the beginning, we have signed, not done yet, but we have signed a new acquisition. It's a classic bolt-on, and as you can see with the recent one, it can be integrated rapidly, well, profitably with a lot of synergies. As you can see when you look specifically at Q3 performance, where the perimeter effect becomes only this acquisition. Then, next, we indicated in the past that we were looking for a partner for the MED project. Well, I believe we are close to have found the first one. This will secure the financing of the next steps. giving precedence in our plans to the completion of the engineering studies for the DFS. Consequently, we will pause the investments in an industrial pilot plant and review this decision in due time and based on market conditions and capital allocation consideration. Last, you know that we relentlessly work on costs through careful management through our operational excellence program called IQube that you heard before. And I believe the EBITDA bridge Sebastian just showed you a few minutes ago confirms the good work done on costs. Nevertheless, we have to acknowledge that today we do not see a significant rebound or a market recovery in the nearby future. We have to make a step up, and the group is launching a comprehensive cost reduction and performance improvement program aiming at achieving significant cost reduction via a leaner, simplified organization and an adjusted industrial footprint with a clear target to improve profitability from 2026 onwards. More details on the program will be available at a later stage. for obvious reason. Thank you. And now I hand over to you for the Q&A session.

Thank you. As a reminder, to ask a question, you will need to press star 1, 1 on your telephone and wait for your name to be announced. To withdraw your question, please press star 1, 1 again. We will take our first question. And the first question comes from the line of Ibrahim Homoni from CIC, please go ahead. Your line is open.

Hello, Alessandro, Sebastian, Cheryl, and thank you for taking my question. I have three, if I may. The first one is about the Europe. You said that it is going better and better. Are the volumes already positive in the region? If not, do you expect that the volume will be positive in Europe? In Q4, my second question is about your... Emily, could you give us more flavor on the investor-interested digital industry or from the automotive industry, and maybe more information on the term of this partnership? And my last question is on graphite and carbon. How do you explain the slowdown of the growth? I notice that it is not a comparison-based effect, as in Q3 2024, the branch was already declining, the low growth, what's the explanation behind this lower growth compared to the H1?

Thank you, Ibrahim. Well, volume in Europe, I remain prudent because we shall be prudent when I look at communications on Q3 coming in the market. I confirm that we believe the worst is behind. Construction in some area is picking up, and I believe automotive will continue to decline in Q4, but most forecasts believe, again, that the bottom is reached, and we should see a positive return of activity, or at least a stabilization. Is it Q4? Is it the beginning of next year? We will see. What will definitely have a positive impact on our business in Europe in Q4 is, if you remember, there is an anti-dumping imposed temporarily but valid on certain Chinese imports of minerals. And this will trigger a volume increase in Q4 for some businesses. If you look specifically at the RAC business, except for graphene carbon, the one posting organic growth, because finally volumes are starting to return with some gain of shares in Europe. So all in all, I am rather positive on Q4 volume development, certainly into next year. On EMILY, as you can imagine, we are in the middle of discussions, by definition, confidential. So we'll be back to you when we can. And I believe it will be relatively short, as we indicated in our press release and in our presentation. But bear with me. At the moment, everything is covered by confidentiality. Graphene and carbon. Whilst the summer period is always a bit to be taken, you have a small month normally in August, so you might see less deviation. Market remains solid. Growth remains solid. We have had some, we have had two issues that have a little impact for sure. We installed SAP in the two operations. And as always, there is some learning of the new system that you have to pay when you do these changes. By the way, we did the same in the US this year. So for sure, this is causing a bit of disruptions. And secondly, when you ramp up at that speed, you need to run your plants, I cannot say flat out, because we have capacity to follow growth for the next three years. but you don't turn the machine on and it goes alone. We are recruiting people. We need to train the people. And frankly, we do have a bit of backlog of orders that we could not supply because we were not able to get all the material out of the door. So, for me, maybe the increase is less than Q2, but there is no negative news from the market that does not confirm the direction. And, of course, the more we grow, the higher the comparison basis will be coming from the past, but really no bad news in any form on GNC.

Many thanks. Thank you very much.

Thank you. Thank you. We will take our next question. Your next question comes from the line of August Dirk from KECK. Please go ahead. Your line is open.

Yes. Good afternoon. My questions are on the quartz GV. Given the weakness of the sector, do you see customers turning to a lower quality product So a product with a lower purity. So in other words, are you losing market share? And the second question still on quartz is still given the situation, do you think that you will be able to receive a dividend from the GV? And if so, what can be the level? And if not, how do you plan to crystallize the value of your stake in this GV. Thanks.

Thank you, August, for the question. Specifically, listen, when you have free capacity in your operations, like it is the case in the value chain of especially solar in China today, of course you try to save money and you try everything you can. Do we believe that we are or we will lose significant market shares in iPurity? No. My view is no. At the moment, I think our customers have been trying to replace this product because of its high price and dependency really on to suppliers for many, many years. It's nothing new. So I believe when the markets will need to run production at strong level, normal level to follow market growth, so once inventories are depleted, and last time we said it might be around mid next year, I think it will become again unavoidable to have the best quality because you will have the best productivity. So I remain of the opinion market share in normal conditions will remain for a high-purity top product. And on the same topic, clearly the year is not as good as last year. Therefore, we have been more careful with the distribution of dividends. We will decide with our partners if and when is the right time. The company is making profit, good profits. You see only half of the net income in our numbers, but if you look really at what is the full potential of this business at EBITDA level, which you see in June and you will see in December, you see that it remains an incredible, high-performing, profitable business. And therefore, we will discuss openly with our partners what is the best for the business and for its shareholders. And based on that, we'll take the decision, which is not taken as of today. But it's part of the discussion we have as shareholders regularly.

Thank you.

Thank you. As a reminder, if you wish to ask a question, please press star 1, 1 on your telephone. We will take our next question. Your next question comes from the line of Sebastian Bray from Berenberg. Please go ahead. Your line is open.

Hello, good evening, and thank you for taking my questions. Can I start with one on the financing costs of the group, please? What is the underlying run rate that is a reasonable assumption for 26, and by when does the company expect to have refinancing in place for the bond that comes due, roughly $600 million? Is it towards the end of the year, or would it expect to have something in the middle? Can I also ask about the review that the group is doing of its cost structure? Is this extending to a portfolio review as well? Are there any further assets that the group feels it could potentially divest as part of these considerations? Thank you.

I let Sébastien answer your first. Good evening Sébastien and welcome to this call. I think it's your first time. I let Sébastien answer on the financing side.

Yes, I will probably not answer extremely precisely. This being said, I think you are You're asking the good question. We have a next big repayment very early in 27. So we pursue a very careful approach. So we will probably refinance that either late this year or in the first half of 2026. so that we are away from, you know, any timing risk. And we will not pre-announce that, but I think we will follow your advice, which is not to do that at the last minute, knowing that on top of that, bond markets are pretty good for corporates these days. Also, I think our careful approach on lithium is actually a good sign that we facilitate refinancing. As far as Van Rijk is concerned, I would say it's a little bit mechanical. We have very detailed of our financing in our program. in our annual report. Obviously, and unfortunately, when we replace an old bond by a new bond, there is a little bit of extra interest rate, mechanical, but that is true for us like the rest of the market.

Thank you, Sébastien. And coming to your Second question, Sebastian. At the moment, there is no plan to significantly review our portfolio. We have done it in the year 23 and 24. Yes, we might sell opportunistically one or the other site, especially if non-performing or not up to our standards, but it will be very punctual and not really On the contrary, as you have seen, we believe we are rather on the acquisition mode, bolt-on, easy, synergetic, profitable if opportunities arise. So cost is really an organizational matter, is a matter of inorganization, simplification. We will review, as I said, our industrial footprints if it still fits the new markets. These tariffs are causing shifts in world production with countries that are favored by more positive, positive tariffs, others that are paying a higher bill. So within our customer base, and that's what I referred to when I said limited direct impact for Emery's, but for our customer, yes, So there might be movements in where we supply our customers that could trigger, as you say, maybe a closure of a site or a divestiture of a site in a country maybe that has been penalized by lower activity. But we really want to work on costs. We are going to use AI to simplify what administrative process is. lean organization and probably give up some nice to-haves that are not affordable when you have challenging market conditions. But the portfolio is the good one. And even the businesses under more pressure, like some businesses in Europe, especially after the energy crisis, if these anti-dumping measures will be confirmed. I do believe there will be market share gains and a return to a very reasonable profitability as expected.

Thank you. Thank you for taking my questions.

Thank you. Once again, if you wish to ask a question, please press star 1-1 on your telephone.

We will take our next question.

Your next question comes from the line of Sven Adderfelt from OdaBHF. Please go ahead, your line is open.

Yes, good evening, gentlemen. I would have two follow-up questions. Alessandro, you mentioned a first investor with regards to lithium. does this suggest the participation will be limited to a 10-ish percentage point participation and therefore you expect maybe some other investor or maybe I misunderstood on the second question on the restructuring cost that you are announcing I don't understand why you are announcing a potential restructuring cost without giving us any number. The second question related to this one is does that mean that given what you have from your team on the ground, you don't expect a recovery before 2027 or 2028? What's the sense of doing it right now? That's my question. Thank you.

Thank you Sven for your questions. The first one is, again, I cannot enter more details as we are in the middle of the discussions, but I can definitely say that your interpretation is not the right one. A partner is a partner and every partner is important and we expect the partner to play a significant role. What I'm saying is that if you look potentially to the end of this project is a very large. Project one day if we go to the end and typically mining in large mining projects, you might have several players joining forces to sustain the capex to bring know how and to develop jointly. So it's it's a. Nothing to be interpreted other than this, partner important, every partner important, and going forward, we will consider interested party in this project if they bring value anytime. On your second one, again, don't interpret that we don't expect any rebound. I expect a rebound in Europe next year. the magnitude to be seen. And when I say I is because all the studies, economic studies we buy by big experts do foresee a recovery in Europe. They're a bit less optimistic on a recovery in the U.S. They believe the first months of next year, the U.S. might be under pressure because of all the turmoil, inflation, uncertainty, and uncertainty is the right word, and then a recovery in the second half of next year. What I believe is that a significant strong rebound is not for the next two, three quarters. Therefore, better be ready with a stronger company, leaner, more efficient, and when volumes come, you know, that's with a 53%, 54%, 55% contribution margin, when volume comes, then we really see a significant improvement in profitability. So we're just doing an extra mile to be stronger, to be more efficient, to be leaner, waiting for a slow or a rapid recovery in the future. So not pushing back anywhere. I do believe 26 or at least forecast say 26 should be good again. But it's not there. And waiting is not an option. We did not communicate more figures. Sven, because there are legal processes and constraints that are being discussed. No decision is taken. There are consultations ongoing, preparation. But latest, by the next communication, we will give for sure all the details in due time when everything has been said, discussed, reviewed, negotiated, approved. So give us the time just to be there.

Thank you very much.

Thank you.

Thank you. There are no further questions. I would like to hand back for closing remarks.

Thank you very much and thank you for all participants for listening to this evening's press release and presentation on EMERIS. Thank you very much. Good evening.

Good evening.

This concludes today's conference call. Thank you for participating.

You may now disconnect. you Thank you. Thank you for watching

Thank you. Thank you. Bye.

Good afternoon or good evening to all of you, and thank you for joining us today to review Imerys' first nine months and Q3 2025 results. Next to me this evening, as usual, Sébastien Rouge, our CFO. And as usual, please let me start by giving you some highlights for the nine months we just closed. Imerys' performance for the nine months is the result of a positive start to the year and a softer second part. Q3 reflected an honestly unexpected slowdown in the U.S. economy as a result of uncertainty caused by the U.S. terrorist policy. Europe, even if overall activity remains low, seems to be turning the corner positively. Revenue for the first nine months were $2,583,000,000, slightly down 0.7%, like for like versus last year. Even in this context, which remains challenging, Imerys posted an EBITDA of 421 million in line with last year, like for like, and excluding the contribution of joint ventures. This demonstrates the resilience of our company, also in difficult times. The adjusted EBITDA for the third quarter, 25, was 140 million, representing a 17% margin. And again, reflecting disciplined pricing policy, ongoing continuous cost management, and positive business dynamic in the polymer and additive businesses. For the full year 2025, the group confirms its adjusted EBITDA target in the range of 540 to 580 million euro. Last importance, as we do not see a significant market recovery, or at least is being delayed, on top of the ongoing actions on costs and i will come back to this the group is launching a comprehensive cost reduction and performance improvement program aimed at simplifying its organization and adjusting its industrial footprint to restore profitability finally some key updates of the quarter first on emily Imerys has received an indication of interest from a potential investor to acquire a minority stake in the Emily Lithium project. Classic, subject to customary due diligence and approvals, this investment will be formalized by the end of January 26 and would allow the completion of the definitive feasibility study of the commercial plant, sometimes around the end of next year. Consequently, any decision concerning future phases, such as the construction of the industrial pilot plant, are on hold and will be made in due course based on market conditions and capital allocation considerations. Second, important good news, Imerys signed today an agreement to purchase SB MineralSao in Brazil. SB Mineração is a Brazilian company specialized in the production of ground calcium carbonate, or GCC, based in Cachoeiro in the state of Espírito Santo. The company is a leading producer of GCC for various applications, in particular polymers, thermosets, paints, and coatings. In 24, the business generated approximately $30 million in revenue with a solid profitability. With this acquisition, Imerys would strengthen its footprint in Brazil, where it is already one of the main producers of carbonates. The completion of the transaction is subject to customary closing conditions, including regulatory approvals. A word on our decarbonization roadmap. We signed an important partnership in October with ENGIE to supply green energy to approximately 25% of our European operations, via a 10-year corporate purchase agreement for the annual generation of 200 gigawatt hour of renewable electricity in Spain. This agreement will enable the reduction of 70,000 tons of CO2 equivalent per year, or 14 percent of our scope two emissions, so a significant step. Our Imerys graphite and carbon business signed two strategic partnerships aiming at enlarging its innovative product portfolio for batteries. One is with Cnano, the global leader in carbon nanotubes. The second one with Shanghai Shanshan, who is the global leader in synthetic graphite for lithium ion batteries. I will not enter the details, and more details are available on our website on the two specific projects. What is important, both partnerships directly address Europe's crucial need for a regional, resilient, and competitive battery supply chain based on state-of-the-art technologies. If we move on now to the next slide, you see Emery sales performance by geography for the first nine months, which is a good picture of the a bit contrasted economic activity by area. Europe, you know, represented about 50% of our sales, or slightly less, enjoyed finally a light recovery in Q3, thanks to improving construction and industrial activity. And you see this if you compare to what we published in July 2017. with the Q2 results. Nevertheless, on a full-year basis, year-to-date, business is still lagging behind last year, and we know due to soft activity in the industrial sector and poor construction markets until recently. North America, the big surprise of the quarter, really subduing Q3, confirming a trend that we have seen at the end of Q2, mostly affected by tariffs. a weak industrial or weak, sorry, residential markets, and a bad quarter infiltration, partly, frankly, relating to our own production issues, relating to CAPEX and some industrial topics. For the nine months, sales are basically flat compared to last year or in line with previous year. We should not forget the significant impact of the devaluation of the US dollar, negatively impacting sale at the level of 4% compared to last year, so becoming significant. In Asia, sales are growing nicely, not only in India, but also in China, which remains quite dynamic, especially around new technologies, electric vehicles, and strong exports in general. South America, Very strong first half, a bit weaker Q3, but I remain confident it will be a good year in South America. The next slide, as usual, a deep dive on what really shows the robustness of Emery's business model. On the left side, you can see the evolution of our adjusted EBITDA year on year. We do have a significant impact of perimeter, as we saw before, coming from the divestiture of the assets serving the pay the paper market, last year in July. End of joint ventures, as we have been discussing since the beginning of this year. FX playing a role, as I mentioned before, but fundamentally the core of Imerys activity remains solid and adjusted EBITDA was resilient, almost flat compared to last year. On the right side, the balance price costs, which highlights the good, continuous work done on cost reductions, first of all, but also on eMERI's agility to react to market changes in terms of pricing when needed. We know this balance remains a key factor for future success. Let's now look at our main underlying markets and their trends. And I'll be quick, as we have partly already addressed the main trajectories and trends by geography. So overall, I would say what we saw in Q2 was confirmed in Q3, with overall markets below expectation, especially construction and automotive, while growth in electrovehicles continues strongly. And while tariffs have a limited direct impact on Imerys, the uncertainty created by these tariffs is impacting more in general business activity and unfortunately specifically some of our customers. To rapidly conclude on this side, construction finally and potentially restarting in Europe remains below expectation in the U.S. Consumer goods, resilient, certainly in the U.S., maybe slowing a bit in America for the reasons we have mentioned. Automotive, continued low production levels in Europe and in North America. China, good, benefited from strong exports, but also these internal stimulus packages or policies launched by the government, and of course, very strong EV growth in the area. General industrial activity, soft in Q2 in Western economies, strong or solid in China. So far for market trends. Sébastien, I hand over to you for more details on our accounts.

Thank you, Alessandro. Good evening, everyone. Let me recap some of the key aspects of our financial performance, and we'll start with revenue. report sales at 2.6 billion for the first nine months of 2025. It represents 0.7% decrease at constant exchange rate and perimeter as compared to last year, with volumes slightly down and prices holding well. You keep in mind the large perimeter effect, 126 million, mainly due to the disposal of the asset serving paper in July 24. We have now an FX impact of minus 47 million, coming from a drop mostly of the USD versus Euro from Q2 onwards. You can see in the chart Imerys' performance for the third quarter alone, quite similar trend for sales volume and prices, and also an high FX impact. Perimeter effect is now positive thanks to the good performance of Chem Viron, the business acquired at the end of last year. If we look now into more details at our three business segments, Beginning with performance minerals, the business generated 1,547,000,000 since the beginning of 25, representing 60% of Imerys Group. Overall, the business shows slightly negative organic growth as compared to last year due to a weak Q3 notably in America. Revenue in Q3 for Americas was down 5.7% at constant scope and exchange rate, reaching 199 million euros. Sales were impacted by a weak residential market in the U.S., suffering from high interest rates, unsold housing inventory, and also a soft filtration market. The prices held well. Revenue in Q3 for EMEA and APAC decreased by 3% like for like in the third quarter of 2025 as compared to last year. Weak volumes, minus 4.1%, were driven by low demand across main markets, where our sales to paints and automotive polymer slightly improved. I already mentioned the good performance of ChemViron's diatomite and perlite businesses, integrated since January 25. Here as well, price grew in line with H1. Now looking at our solutions for refractory, abrasives, and construction business. We note a relative improvement of the business in Q3. posting organic growth in the quarter after a difficult H1. Business revenue reached $278 million in Q3, an increase of 1.9% as compared to last year at constant scope and exchange rate. The recovery is primarily driven by stronger refractory activity benefiting from positive momentum in the US and China. and some volume gains in Europe. In contrast, the construction business experienced a more mixed performance, impacted by soft-end markets. In this business, prices as well held well. Now, let's complete this segment review with the solutions for energy transition. Q3 revenues for graphite and carbon amounted to 59 million, A 3.6% increase compared to last year at constant scope and exchange rate. Sales growth is still driven by robust end markets, primarily electric vehicles. The business also benefited from successful new product launches, in particular in polymer applications. A small note on the quartz corporation, our high purity quartz JV, 50% owned by Imerys and not consolidated as you remember. The activity is showing some signs of normalization. However, these have yet to be confirmed as the solar value chain remains affected by persistent high inventories and the lack of significant reduction in production capacity. Now, let's look at the group profitability. For the first nine months, adjusted EBITDA reached 421 million. It decreased by 21% as compared to last year, reflecting the impact of lower contribution of JVs, perimeter impact, and an unfavorable exchange rate effect of minus 11 million. EMERIS achieved and adjusted EBDA margin of 16.3% at the end of Q3-25. This was supported by improved performance in graphite and carbon, resilient activity in performance mineral, and a continuous cost management approach. Adjusted EBDA Q3-25 decreased by 6%, impacted by volume decrease and a 10 million FX impact. which were partly offset by a positive price-cost balance in this quarter again. Ongoing cost-saving initiatives allowed the group to keep fixed costs and overhead slightly lower than last year in absolute value, fully offsetting inflation. If we look now at the other elements of our income statement for the first nine months of this year, Driven by the decrease of EBITDA in absolute value, current operating income reached $216 million. With slightly higher interest expenses and lower income tax, current and empty income from continuing operation ended up at $126 million at the end of September. You remember that last year, the group booked 326 million in non-cash expenses, mostly originating from the translation reserves associated with the assets serving the paper market that we divested in July 24. This year, in the first nine months of 25, other operating expenses were limited to 16 million. Year-to-date net profit is therefore positive, reaching 110 million at the end of September. I now hand over back to Alessandro for the outlook.

Thank you, Sébastien. So, let me conclude with some good news. First, we remain confident of achieving our guidance, which is not a given under current market circumstances. Second, I'd like to inform you that the date has been set by the relevant court to resume the confirmation hearing on our Chapter 11 case in the U.S. This is now planned to start on February 2nd next year. Yes, we all wish it could be earlier, but this was the first available date provided by the court. What is important is having a date for this crucial hearing is a very important step towards the end of this process. Third, as you have seen at the beginning, we have signed, not done yet, but we have signed a new acquisition. It's a classic bolt-on, and as you can see with the recent one, it can be integrated rapidly, well, profitably with a lot of synergies. As you can see when you look specifically at Q3 performance, where the perimeter effect becomes only this acquisition. Then, next, we indicated in the past that we were looking for a partner for the MED project. Well, I believe we are close to have found the first one. This will secure the financing of the next steps. giving precedence in our plans to the completion of the engineering studies for the DFS. Consequently, we will pause the investments in an industrial pilot plant and review this decision in due time and based on market conditions and capital allocation consideration. Last, you know that we relentlessly work on costs through careful management our operational excellence program called IQube that you heard before. And I believe the EBITDA bridge Sebastian just showed you a few minutes ago confirms the good work done on costs. Nevertheless, we have to acknowledge that today we do not see a significant rebound or a market recovery in the nearby future. Therefore, We have to make a step up, and the group is launching a comprehensive cost reduction and performance improvement program aiming at achieving significant cost reduction via a leaner, simplified organization and an adjusted industrial footprint with a clear target to improve profitability from 2026 onwards. More details on the program will be available at a later stage. for obvious reasons. Thank you. And now I hand over to you for the Q&A session.

Thank you. As a reminder, to ask a question, you will need to press star 1, 1 on your telephone and wait for your name to be announced. To withdraw your question, please press star 1, 1 again. We will take our first question. And the first question comes from the line of Ibrahim Homoni from CIC, please go ahead. Your line is open.

Hello, Alessandro, Sebastian, Cheryl, and thank you for taking my question. I have three, if I may. The first one is about the euro. You said that it is going better and better. Are the volumes already positive in the region? If not, do you expect that the volume will be positive in In Q4, my second question is about your... Emily, could you give us more flavor on the investor-interested digital and industrial from the automotive industry, and maybe more information on the term of this partnership? And my last question is on graphite and carbon. How do you explain the slowdown of the growth? I notice that it is not a comparison-based effect, as in Q3 2024, the branch was already declining. the low growth, what's the explanation behind this lower growth compared to the H1?

Thank you, Ibrahim. Well, volume in Europe, I remain prudent because we shall be prudent when I look at communications on Q3 coming in the market. I confirm that we believe the worst is behind. Construction in some area is picking up, and I believe automotive will continue to decline in Q4, but most forecasts believe, again, that the bottom is reached and we should see a positive return of activity or at least a stabilization. Is it Q4? Is it the beginning of next year? We will see. What will definitely have a positive impact on our business in Europe in Q4 is, if you remember, there is an anti-dumping imposed temporarily, but valid on certain Chinese imports of minerals. And this will trigger a volume increase in Q4 for some businesses. If you look specifically at the RAC business, it was the except for graphene carbon, the one posting organic growth, because finally volumes are starting to return with some gain of shares in Europe. So all in all, I am rather positive on Q4 volume development, certainly into next year. On Emily, as you can imagine, we are in the middle of discussions, by definition, confidential. So we'll be back to you when we can. And I believe it will be relatively short, as we indicated in our press release and in our presentation. But bear with me at the moment. Everything is covered by confidentiality. Graphene and carbon. Whilst the summer period is always a bit to be taken, you have a small month normally in August, so you might see less deviation. Market remains solid. Growth remains solid. We have had some, we have had two issues that have a little impact for sure. We installed SAP in the two operations. And as always, there is some learning of the new system that you have to pay when you do these changes. By the way, we did the same in the US this year. So for sure, this is causing a bit of disruptions. And secondly, when you ramp up at that speed, you need to run your plans, I cannot say flat out, because we have capacity to follow growth for the next three years. but you don't turn the machine on and it goes alone. We are recruiting people. We need to train the people. And frankly, we do have a bit of backlog of orders that we could not supply because we were not able to get all the material out of the door. So for me is maybe the increase is less than Q2, but there is no negative news from the market that does not, confirm the direction. And of course, the more we grow, the higher the comparison basis will be coming from the past, but really no bad news in any form on GNC.

Many thanks. Thank you very much. Thank you.

Thank you. We will take our next question. Your next question comes from the line of August Dirk from KECK. Please go ahead, your line is open.

Yes, good afternoon. My questions are on the quartz GV. Given the weakness of the sector, do you see customers turning to a lower quality product, so a product with a lower purity? In other words, are you losing market share? And the second question, still on quarts is still giving the situation. Do you think that you will be able to receive a dividend from the GV? And if so, what can be the level? And if not, how do you plan to crystallize the value of your stake in this GV? Thanks.

Thank you, August, for the question, specifically Listen, when you have free capacity in your operations, like it is the case in the value chain of especially solar in China today, of course you try to save money and you try everything you can. Do we believe that we are or we will lose significant market shares in high purity No. My view is no. At the moment, I think our customers have been trying to replace this product because of its high price and dependency really on two suppliers for many, many years. It's nothing new. So I believe when the markets will need to run production at a strong level, a normal level to follow market growth, so once inventories are depleted, Last time we said it might be around mid next year. I think it will become again unavoidable to have the best quality because you will have the best productivity. So I remain of the opinion market share in normal conditions will remain for a high purity top product. And on the same topic, clearly the year is not as good as last year. Therefore, we have been more careful with the distribution of dividends. We will decide with our partners if and when is the right time. The company is making profit, good profits. You see only half of the net income in our numbers, but if you look really at what is the full potential of this business at EBITDA level, which you see in June and you will see in December, you see that it remains an incredible, high-performing, profitable business. And therefore, we will discuss openly with our partners what is the best for the business and for its shareholders. And based on that, we'll take the decision, which is not taken as of today. But it's part of the discussion we have as shareholders regularly.

Thank you.

Thank you. As a reminder, if you wish to ask a question, please press star 1, 1 on your telephone. We will take our next question. Your next question comes from the line of Sebastian Bray from Berenberg. Please go ahead. Your line is open.

Hello. Good evening, and thank you for taking my questions. Can I start with one on the financing costs of the group, please? What is the underlying run rate that is a reasonable assumption for 26? And by when does the company expect to have refinancing in place for the bond that comes to you, roughly 600 million? Is it towards the end of the year or would it expect to have something in the middle? Can I also ask about the review that the group is doing of its cost structure? Is this extending to a portfolio review as well? Are there any further assets that the group feels it could potentially divest as part of these considerations? Thank you.

I'll let Sébastien answer you first. Good evening, Sébastien, and welcome to this call. I think it's your first time. I let Sébastien answer on the financing side.

Yes, I will probably not answer extremely precisely. This being said, I think you're asking the good question. We have a next big repayment very early in 27, so we pursue a very careful approach. So we will probably refinance that either late this year or in the first half of 2026. so that we are away from any timing risk. And we will not pre-announce that, but I think we will follow your advice, which is not to do that at the last minute, knowing that on top of that, bond markets are pretty good for corporates these days. Also, I think our careful approach on lithium is actually a good sign that we facilitate refinancing. As far as van rijk is concerned, I would say it's a little bit mechanical. We have very detailed of our financing in our in our annual report obviously and unfortunately when we we replace a new an old bone by a new bone there is a little bit of a of extra of extreme stress rate mechanical but but that i would say is true for us like the rest of the market thank you sebastian and coming to your

Second question, Sebastian. At the moment, there is no plan to significantly review our portfolio. We have done it in the year 23 and 24. Yes, we might sell opportunistically one or the other site, especially if non-performing or not up to our standards, but it will be very punctual and not really On the contrary, as you have seen, we believe we are rather on the acquisition mode, bolt-on, easy, synergetic, profitable if opportunities arise. So cost is really an organizational matter, is a matter of inorganization, simplification, We will review, as I said, our industrial footprints if it still fits the new markets. These tariffs are causing shifts in world production with countries that are favored by more positive, positive tariffs, others that are paying a higher bill. So within our customer base, and that's what I referred to when I said limited direct impact for Emery's, but for our customer, yes, So there might be movements in where we supply our customers that could trigger, as you say, maybe a closure of a site or a divestiture of a site in a country maybe that has been penalized by lower activity. But we really want to work on costs. We are going to use AI to simplify what administrative process is. lean organization and probably give up some nice to-haves that are not affordable when you have challenging market conditions. But the portfolio is the good one. And even the businesses under more pressure, like some businesses in Europe, especially after the energy crisis, if these anti-dumping measures will be confirmed. I do believe there will be market share gains and a return to a very reasonable profitability, as expected.

Thank you. Thank you for taking my questions.

Thank you. Once again, if you wish to ask a question, please press star 1-1 on your telephone.

We will take our next question.

Your next question comes from the line of Sven Adderfelt from OdaBHF. Please go ahead, your line is open.

Yes, good evening, gentlemen. I would have two follow-up questions. Alessandro, you mentioned a first investor with regards to lithium. Does this suggest the participation will be limited to a 10-ish percentage point participation and therefore you expect maybe some other investor or maybe I misunderstood on the second question on the restructuring cost that you are announcing I don't understand why you are announcing a potential restructuring cost without giving us any number. The second question related to this one is does that mean that given what you have from your team on the ground, you don't expect a recovery before 2027 or 2028? What's the sense of doing it right now? That's my question. Thank you.

Thank you, Sven, for your questions. The first one is, again, I cannot enter more details as we are in the middle of the discussions, but I can definitely say that your interpretation is not the right one. A partner is a partner, and every partner is important, and we expect the partner to play a significant role. What I'm saying is that if you look potentially to the end of this project is a very large project one day if we go to the end and typically in large mining projects you might have several players joining forces to sustain the CAPEX to bring know-how and to develop jointly. So it's a Nothing to be interpreted other than this, partner important, every partner important, and going forward, we will consider interested party in this project if they bring value anytime. On your second one, again, don't interpret that we don't expect any rebound. I expect a rebound in Europe next year. the magnitude to be seen. And when I say I is because all the studies, economic studies we buy by big experts do foresee a recovery in Europe. They're a bit less optimistic on a recovery in the U.S. They believe the first months of next year, the U.S. might be under pressure because of all the turmoil, inflation, uncertainty, and uncertainty is the right word, and then a recovery in the second half of next year. What I believe is that a significant strong rebound is not for the next two, three quarters. Therefore, better be ready with a stronger company, leaner, more efficient. And when volumes come, you know, that's with a 53, 54, 55% contribution margin. When volume comes, then we really see a significant improvement in profitability. So we're just doing an extra mile to be stronger, to be more efficient, to be leaner, waiting for a slow or a rapid recovery in the future. So not pushing back anywhere. I do believe 26, or at least the forecast say 26 should be good again. But it's not there. And waiting is not an option. We did not communicate more figures. Sven, because there are legal processes and constraints that are being discussed. No decision is taken. There are consultations ongoing, preparation. But latest, by the next communication, we will give for sure all the details in due time when everything has been said, discussed, reviewed, negotiated, approved. So give us the time just to be there.

Thank you very much.

Thank you. Thank you. There are no further questions. I would like to hand back for closing remarks.

Thank you very much, and thank you for all participants for listening to this evening's press release and presentation on Imerys. Thank you very much. Good evening.

Good evening. Bye-bye.